SPS
CDNA icon

Susquehanna Portfolio Strategies’s CareDx CDNA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
+45,122
New +$982K 0.02% 523

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna Portfolio Strategies's CDNA Position: Q2 2026 in Review

Susquehanna Portfolio Strategies opened a new position in CareDx (CDNA) in Q2 2026: 45,122 shares worth $1.29M. The stake represents 0.02% of the portfolio and ranks #523 among its holdings.

227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Susquehanna Portfolio Strategies held 45,122 shares of CareDx worth $1.29M as of Q2 2026.
  • CareDx was a new Susquehanna Portfolio Strategies position in Q2 2026.
  • CareDx made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #523 holding.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.